Immune Activation Following Spinal Cord Injury: A Review Focused on Inflammatory Changes in the Spinal Cord
International Journal of Molecular Sciences · 02.10.2025 · 26 (19) · 9624
DOI: 10.3390/ijms26199624 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 02.10.2025. Verfasst von Diogo Nascimento und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedicine, Experimental Biology Unit, Faculty of Medicine of Porto, University of Porto, Alameda Prof. Hernâni Monteiro, 4200-319 Por…. Hauptthemen laut MEDLINE: Spinal Cord Injuries, Spinal Cord, Inflammation. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 201 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação para a Ciência e Tecnologia, i3S—Instituto de Investigação e Inovação em Saúde da Universidade do Porto, FCT- Fundação para a Ciência Tecnologia.
Abstract (Originalsprache)
Spinal cord injury (SCI) poses a substantial physical, psychological and social burden. Although many therapies are currently available, it is still impossible to fully restore the lost organic functions of SCI patients. An important event in SCI physiopathology is the development of a neuron-repulsive fibrotic scar at the lesion site, a barrier that hampers neuronal growth and contributes to long-term functional impairment. This neuron-repulsive scar is present in severe spinal cord injuries in humans but is absent in some animals capable of natural regeneration. In humans and other mammals, various immune cells take part in the development and maturation of the glial scar, and cytokines and other molecular factors regulate the associated histologic changes. Pro-inflammatory cytokines and complement system proteins tend to be overexpressed early after SCI, but anti-inflammatory cytokines also participate in the remodelling of the injured tissue by regulating the excessively pro-inflammatory environment. This inflammatory regulation is not entirely successful in humans, and inflammation inhibitor drugs offer promising avenues for SCI treatment. Some non-specific immunosuppressor drugs have already been studied, but targeted modulation therapies may be more efficient and less prone to secondary effects. Continued experimental research and clinical trials are vital to advance findings and develop effective treatments, aiming to overcome the barriers to spinal cord regeneration and improve recovery for SCI patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedicine, Experimental Biology Unit, Faculty of Medicine of Porto, University of Porto, Alameda Prof. Hernâni Monteiro, 4200-319 Porto, Portugal.
- Department of Otolaryngology, Unidade Local de Saúde de Entre o Douro e Vouga, 4520-211 Santa Maria da Feira, Portugal.
- Pain Neurobiology, Instituto de Investigação e Inovação em Saúde-i3S and IBMC, University of Porto, 4200-135 Porto, Portugal.
ORCID-Profile: Diogo Nascimento, Ana Ferreira, Célia Duarte Cruz
Förderung
- Fundação para a Ciência e Tecnologia
- i3S—Instituto de Investigação e Inovação em Saúde da Universidade do Porto
- FCT- Fundação para a Ciência Tecnologia
Zitieren
APA
Nascimento, D., Ferreira, A., & Cruz, C. D. (2025). Immune Activation Following Spinal Cord Injury: A Review Focused on Inflammatory Changes in the Spinal Cord. International Journal of Molecular Sciences, 26(19), 9624. https://doi.org/10.3390/ijms26199624
Vancouver
Nascimento D, Ferreira A, Cruz CD. Immune Activation Following Spinal Cord Injury: A Review Focused on Inflammatory Changes in the Spinal Cord. International Journal of Molecular Sciences. 2025;26(19):9624. doi:10.3390/ijms26199624
BibTeX
@article{Nascimento2025,
author = {Nascimento, Diogo and Ferreira, Ana and Cruz, Célia Duarte},
title = {Immune Activation Following Spinal Cord Injury: A Review Focused on Inflammatory Changes in the Spinal Cord},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {19},
pages = {9624},
doi = {10.3390/ijms26199624}
}
EUVIMED